Briefing

The Briefing: Couchbase Files Confidentially For IPO, Skeleton Unearths $61M, And More

Here’s what you need to know today in startup and venture news, updated by the Crunchbase News staff throughout the day to keep you in the know.

Subscribe to the Crunchbase Daily

Database company Couchbase said to file confidentially for IPO

Santa Clara, California-based Couchbase, developer of a distributed NoSQL cloud database, has filed confidentially for an initial public offering, according to a Reuters report citing unnamed sources.

The offering reportedly could set a value of up to $3 billion for the 12-year-old company. Previously, Couchbase raised $251 million in known funding, per Crunchbase data, from Accel and other well-known venture and strategic backers.

The company is reportedly generating revenue in excess of $100 million annually, a common threshold for companies eyeing public markets.

— Joanna Glasner

Funding rounds

Skeleton Technologies raises $61M: Estonian energy storage startup Skeleton Technologies has raised another €51 million ($61 million) to boost the production of its ultracapacitors. Funding came from Germany’s Federal Ministry for Economic Affairs and Energy, and the Free State of Saxony, where Skeleton operates a factory.

— Joanna Glasner

Assembled lands $16.6M for work management platform: Assembled, a San Francisco-based startup developing a work management platform for customer support teams, raised $16.6 million in a Series A round led by Emergence Capital1.

—  Joanna Glasner

M&A

CELLINK buys MatTek: Less than a month after acquiring Finland-based robotics and diagnostic automation company Ginolis, Swedish biotech CELLINK, a developer of “bioinks” targeted for use in printing tissues, is buying another company, this time agreeing to acquire Ashland, Massachusetts-based MatTek, a provider of advanced in vitro technology for clinical and tissue model innovation, cell isolation and cell culture, for $68 million in cash and stock.

— Joanna Glasner and Christine Hall

Illustration: Dom Guzman


  1. Emergence Capital is an investor in Crunchbase. It has no say in our editorial process. For more, head here.

Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.

Copy link